Stay updated on FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    New guidance and navigation sections have been added to help users read the study record and join the study. Recruitment status indicates no longer looking for participants, and the page revision was updated from v3.5.5 to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-15T15:54:37.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5, indicating a maintenance or feature update to the page rendering.
    Difference
    0.0%
    Check dated 2026-06-08T15:15:20.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4 on the page, indicating a newer version of the content.
    Difference
    0.0%
    Check dated 2026-05-18T03:44:50.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The version/release label at the bottom of the page was updated from Revision: v3.5.0 to Revision: v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-26T08:21:30.000Z thumbnail image
  6. Check
    85 days ago
    Change Detected
    Summary
    Location in Italy updated from Padua to Padova (35128); the Padova site is now listed and the Padua listing removed.
    Difference
    0.0%
    Check dated 2026-04-04T19:00:47.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. No changes to study data or page layout.
    Difference
    0.0%
    Check dated 2026-03-21T08:46:55.000Z thumbnail image

Stay in the know with updates to FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page.